NEWS & EVENTS
NEWSLETTERS ARCHIVE
EVENTS
Analytical Procedures & Methods Validation
December 4-6, 2017 The laboratory landscape continues to face an influx of regulations surrounding the reliability, consistency and accuracy of analytical methods and data. From FDA’s final guidance on analytical procedures to USP chapter updates to FDA and MHRA’s...
read moreRECENT NEWS
May 2018 Newsletter
...
read moreDecember 2017 Newsletter
...
read moreJuly 2017 Newsletter
...
read more
December 2016 Newsletter
Arlenda nominated 3 years in a row among the fastest growing technologies company : ranked 39th Thanks to a noticeable growth of 112% since 2014, Arlenda was nominated for the third time by Deloitte among the FAST50 high tech companies in Belgium. This year, Arlenda...
read more
September 2016 Newsletter
Strong presence of Arlenda at BAYES2016 in Leuven, Belgium on May 17-20 th, 2016. Arlenda’s scientists were selected to present 4 talks and 1 poster, reflecting the recognized expertise of Arlenda in applied Bayesian statistics for pharmaceutical industry. The talks...
read more
November 2015 Newsletter
...
read more
September 2015 Newsletter
...
read more
June 2015 Newsletter
...
read more
February 2015 Newsletter
...
read more
January 2015 Newsletter
...
read more
Statistical Software and Consulting experts for the statistical management of the development and manufacturing of your products.
Arlenda is a member of the international group PharmaLex, supporting our rapid expansion.
CONTACT INFO
Arlenda Head Office (Belgium) Rue Edouard Belin, 5 1435 Mont-St-Guibert Belgium Phone: +32 10 46 10 10
Arlenda Liège Office (Belgium) Avenue du Parc Industriel, 89 4041 Milmort Belgium Phone: +32 10 46 10 10
Arlenda, Inc. (U.S.) 128 Orchard Way, Berwyn, PA 19312 USA Phone: +1 (908) 3462181
RECENT NEWS & EVENTS
Analytical Procedures & Methods Validation
December 4-6, 2017 The laboratory landscape continues to face an influx of regulations surrounding the reliability, consistency and accuracy of analytical methods and data. From FDA’s final guidance on analytical procedures to USP chapter updates to FDA and MHRA’s...